Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis Clinical Trial

Official title:

Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04953481
• Other study ID #: M2021023
• Status: Recruiting
• Start date: January 1, 2021
• Est. completion date: December 31, 2022

Study information

• Verified date: July 2021
• Source: Peking University Third Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to comprehensively investigate and analyze the home care needs and status quo of ALS patients in China, and to clarify their home care needs and status quo, so as to provide reference for the development of home care service planning and policy measures for ALS patients.

Description:

Amyotrophic lateral sclerosis (ALS) is the most common type of motor neuron disease. It is common in middle-aged and elderly people. Progressive skeletal muscle weakness, atrophy, fascicular fibrillation, bulbar paralysis and pyramidal tract sign are the main clinical manifestations. The survival time is usually 3-5 years. As the pathogenesis of ALS is not fully understood, there is no specific treatment for ALS. The clinical treatment mode of most patients with ALS is hospitalization at the end of the disease and maintenance treatment at home during the disease progression. At present, there are few reports on the home care needs and nursing status of ALS patients in China. This study is a cross-sectional survey. Based on consulting the relevant literature and consulting experts' opinions, the researchers designed the questionnaire of home care needs and nursing status of ALS patients, The convenience sampling method was used to select 126-252 ALS outpatients, 126-252 ALS inpatients, and 126-252 ALS family members from a third class a general hospital in Beijing. The needs and status of home care of ALS patients in China were comprehensively investigated and analyzed, and the needs and status of home care were clarified, so as to provide reference for the development of home care service planning and policy measures for ALS patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 252
• Est. completion date: December 31, 2022
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

-

The inclusion criteria of ALS patients:

1. They met the diagnostic criteria of Chinese guidelines for the diagnosis and treatment of amyotrophic lateral sclerosis; ? Receiving care at home; ? No cognitive impairment (if the patient is unable to talk and write due to illness, the family members can express it for the patient); ? Informed consent, willing to participate in this study; ? No mental illness. The inclusion criteria of caregivers: ? the primary caregiver designated by the patient was responsible for the primary care;

• They are relatives of patients;
• No payment for care; ? Informed consent, willing to participate in this study;
• No mental illness; ? There was no cognitive impairment. Exclusion Criteria: - Exclusion criteria of ALS patients: ? severe physical diseases, such as malignant tumor, liver and kidney dysfunction, etc; ? They are participating in other intervention projects.

Exclusion criteria of caregivers:

• severe physical diseases, such as malignant tumor, liver and kidney dysfunction, etc; ? They are participating in other intervention projects.

Related Conditions & MeSH terms

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease
• Sclerosis

Intervention

Other:
• survey
The general information, home care status and functional status of ALS patients and family caregivers were collected.

Locations

Country	Name	City	State
China	Peking University Third Hospital	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the Barthel index of ADL	the Barthel index of ADL	At the time of survey (day 0)
Secondary	Caregiver Burden Inventory, CBI	Caregiver Burden Inventory, CBI	At the time of survey (day 0)